Beauty news without the noise.
New launches, product updates, research, and industry developments—reported from primary sources and explained for shoppers without display ads, pop-ups, hype, or clickbait.
Allies of Skin Launches Peptint Peptide Lip Treatment
Allies of Skin is entering lip care with Peptint, a $39 treatment-gloss backed by a one-use finished-product dryness claim. Here’s what shoppers should know.
AXIS-Y Launches Triple PDRN Barrier Boost Serum With Plant-Derived PDRN
AXIS-Y is launching a barrier serum built around plant-derived PDRN, NAD+, and peptides. Here’s what shoppers should know about the PDRN claim and the early clinical results.
Tome Foundational Treatment Opens for Preorder With Bioneedle Spicule Skincare
Tome Foundational Treatment is open for U.S. preorder at $178 for four once-weekly spicule treatments. Here’s what shoppers should know about the price, evidence, and potential tradeoffs.
Sephora Adds Exosome, PDRN, and NAD Skincare From Korean Brands
New Korean skincare at Sephora is putting exosomes, PDRN, and NAD in front of mainstream U.S. shoppers. Here’s what those ingredient names do—and do not—tell you.
Beverly Hills MD Launches ProRetinol Advanced Eye Complex
Beverly Hills MD has launched a $99 retinol eye serum for fine lines, dark circles, puffiness, and sagging-looking lids. Here’s what shoppers should know about the formula and evidence.
Obagi Launches CLENZIderm M.D. Resurfacing Multi-Acid Peel Pads
Obagi's $100 CLENZIderm M.D. peel pads disclose the concentrations of four exfoliating acids. Here’s what that tells shoppers—and what it still doesn’t.